Pfizer Plans to Seek Booster Approval for 16- and 17-Year-Olds by aguilarfamilyh | Dec 1, 2021 | Uncategorized | 0 comments Pfizer and BioNTech plan to apply for FDA authorization this week for a booster COVID-19 vaccine for 16- and 17-year-olds. Submit a Comment Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment.
Recent Comments